These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8284337)

  • 1. Secondary prevention of ischemic heart disease. The case for aggressive behavioral monitoring and intervention.
    Ketterer MW
    Psychosomatics; 1993; 34(6):478-84. PubMed ID: 8284337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of emotions as a risk factor for ischemic heart disease.
    Marusic A; Belsak K; Marusic D
    Psychiatr Danub; 2008 Mar; 20(1):31-6. PubMed ID: 18376328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological correlates of early onset of ischemic heart disease in a sample drawn from a Pakistani population.
    Rafique R; Amjad N
    Int J Psychol; 2013; 48(4):616-24. PubMed ID: 22734605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of personality traits on rehabilitation of patients with ischemic heart disease after aortocoronary bypass].
    Zamotaev IuN; Kosov VA; Kremnev IuA; Antoshina IN
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (6):7-10. PubMed ID: 11868544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological effects of a short behavior modification program in patients with acute myocardial infarction or coronary artery bypass grafting. A randomized controlled trial.
    Sebregts EH; Falger PR; Appels A; Kester AD; Bär FW
    J Psychosom Res; 2005 May; 58(5):417-24. PubMed ID: 16026656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice.
    Starkey C; Michaelis J; de Lusignan S
    Public Health; 2000 May; 114(3):169-75. PubMed ID: 10878743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences and similarities in ischemic heart disease in men and women].
    Piwowarska W; Zylińska M
    Folia Med Cracov; 1991; 32(1-2):43-56. PubMed ID: 1843699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive/behavioral therapy of anxiety in the medically ill: cardiac settings.
    Ketterer MW
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):148-53. PubMed ID: 10378957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary prevention of ischemic heart disease.
    Bittner V
    Curr Opin Cardiol; 1994 Jul; 9(4):417-27. PubMed ID: 7919586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness of estrogen replacement therapy to reduce ischemic heart disease--revaluation].
    Ben-Chetrit A; Zacut D; Shimonovitz S
    Harefuah; 2003 Jan; 142(1):32-7, 78. PubMed ID: 12647487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic heart disease in women: a review for primary care physicians.
    Kusnoor AV; Ferguson AD; Falik R
    South Med J; 2011 Mar; 104(3):200-4. PubMed ID: 21297529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral approaches to secondary prevention of coronary heart disease.
    Blumenthal JA; Levenson RM
    Circulation; 1987 Jul; 76(1 Pt 2):I130-7. PubMed ID: 3297396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan.
    Gaffey AE; Spatz ES
    Curr Atheroscler Rep; 2024 Mar; 26(3):45-58. PubMed ID: 38240928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
    J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should individuals without evidence of coronary disease and with risk factors receive continuous treatment with aspirin? Arguments in favor].
    Calvo F; Barrabés JA; García-Dorado D
    Rev Esp Cardiol; 1996 Nov; 49(11):793-800. PubMed ID: 9082488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol: an important but relatively overemphasized risk factor for ischemic heart disease.
    Hellstrom HR
    Med Hypotheses; 2001 Nov; 57(5):593-601. PubMed ID: 11735317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms of fatigue and depression in ischemic heart disease are driven by personality characteristics rather than disease stage: a comparison of CAD and CHF patients.
    Smith OR; Pedersen SS; Van Domburg RT; Denollet J
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):583-8. PubMed ID: 18830086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.